EOLS,COO Stock Price and Quote

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change -0.71
Percentage change -7.13	%

Peers: ABBV LLY PFE AMGN BMY RVNC MRK TEVA PRGO PRPH

| Held by: VTI IWM VXF IWO VTWO SCHA VHT XPH IHE IWC

Index	RUT	P/E	-	EPS (ttm)	-0.89	Insider Own	11.75%	Shs Outstand	64.45M	Perf Week	-6.28%
Market Cap	596.40M	Forward P/E	16.35	EPS next Y	0.57	Insider Trans	-3.95%	Shs Float	56.90M	Perf Month	-4.64%
Income	-56.20M	PEG	-	EPS next Q	-0.10	Inst Own	84.37%	Short Float	16.99%	Perf Quarter	-30.35%
Sales	275.46M	P/S	2.17	EPS this Y	23.26%	Inst Trans	5.53%	Short Ratio	9.20	Perf Half Y	-20.12%
Book/sh	-0.10	P/B	-	EPS next Y	393.56%	ROA	-25.57%	Short Interest	9.67M	Perf Year	-20.16%
Cash/sh	1.05	P/C	8.78	EPS next 5Y	-	ROE	-949.46%	52W Range	8.67 - 17.82	Perf YTD	-16.21%
Dividend Est.	-	P/FCF	-	EPS past 5Y	23.91%	ROIC	-46.21%	52W High	-48.09%	Beta	1.00
Dividend TTM	-	Quick Ratio	2.16	Sales past 5Y	50.12%	Gross Margin	66.43%	52W Low	6.69%	ATR (14)	0.55
Dividend Ex-Date	-	Current Ratio	2.34	EPS Y/Y TTM	15.00%	Oper. Margin	-13.02%	RSI (14)	39.21	Volatility	3.44% 3.41%
Employees	332	Debt/Eq	-	Sales Y/Y TTM	25.38%	Profit Margin	-20.40%	Recom	1.00	Target Price	23.57
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	-33.00%	Payout	-	Rel Volume	2.14	Prev Close	9.96
Sales Surprise	-5.31%	EPS Surprise	-5.39%	Sales Q/Q	15.49%	Earnings	May 07 AMC	Avg Volume	1.05M	Price	9.25
SMA20	-5.14%	SMA50	-9.97%	SMA200	-28.72%	Trades		Volume	2,316,895	Change	-7.13%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-17-25	Initiated	BTIG Research	Buy	$21
Jan-29-24	Upgrade	Barclays	Equal Weight → Overweight	$10 → $16
Jun-23-22	Initiated	Needham	Buy	$18
May-12-22	Upgrade	Barclays	Underweight → Equal Weight	$8 → $10
Jan-20-22	Upgrade	Truist	Hold → Buy	$11
May-06-21	Upgrade	Mizuho	Neutral → Buy	$15
Apr-08-21	Reiterated	H.C. Wainwright	Buy	$20 → $22
Feb-24-21	Downgrade	Truist	Buy → Hold	$12
Jul-07-20	Downgrade	Mizuho	Buy → Neutral	$8 → $3
Feb-06-20	Resumed	Mizuho	Buy
Nov-26-19	Initiated	SVB Leerink	Outperform	$25
Sep-05-19	Resumed	Mizuho	Buy	$30
Jun-28-19	Initiated	Wells Fargo	Market Perform	$16
Jun-11-19	Initiated	Barclays	Underweight	$13
Mar-20-19	Initiated	SunTrust	Buy	$30
Feb-14-19	Initiated	H.C. Wainwright	Buy	$37
Jan-29-19	Initiated	Stifel	Buy	$27

Show Previous Ratings

Jun-13-25 04:05PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jun-10-25 08:00AM	Evolysse Recognized in 2025 Shape Skin Awards (Business Wire)
May-27-25 04:15PM	Evolus Announces Departure of its Chief Financial Officer (Business Wire) -5.20%
May-22-25 08:00AM	Evolus Announces Publication of U.S. Pivotal Study for Evolysse Form and Evolysse Smooth Injectable Hyaluronic Acid Gels (Business Wire)
May-16-25 04:05PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
09:51AM	Loading…
May-13-25 09:51AM	Evolus, Inc. (EOLS): A Bull Case Theory (Insider Monkey)
May-08-25 09:47AM	Q1 2025 Evolus Inc Earnings Call (Thomson Reuters StreetEvents) -14.20%
03:28AM	Evolus Inc (EOLS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com)
May-07-25 07:14PM	Evolus projects $345M-$355M revenue for 2025 with new product launches (Seeking Alpha)
07:13PM	Evolus, Inc. (EOLS) Q1 2025 Earnings Call Transcript (Seeking Alpha)
06:55PM	Evolus, Inc. (EOLS) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Evolus Reports First Quarter 2025 Results (Business Wire)
May-05-25 04:05PM	Evolus Strengthens Balance Sheet with Refinancing; Reducing Cost of Capital and Expanding Financial Flexibility (Business Wire)
May-01-25 07:30AM	SNDL Inc. (SNDL) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
Apr-30-25 10:01AM	Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know (Zacks)
08:00AM	Loading…
Apr-23-25 08:00AM	Evolus to Report First Quarter Financial Results on May 7, 2025 (Business Wire) +7.36%
Apr-22-25 07:10PM	Evolus: Two-Product Aesthetics Company With A Competitive Edge (Seeking Alpha)
Apr-18-25 04:05PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-16-25 08:00AM	Evolus Announces Commercial Launch of Evolysse (Business Wire)
Apr-15-25 08:00AM	Evolus Launches "Drop the F Word" Campaign in Advance of the Commercial Launch of Evolysse Injectable Hyaluronic Acid Gels (Business Wire)
Mar-25-25 08:00AM	Evolus to Participate in The Needham 24th Annual Virtual Healthcare Conference (Business Wire)
Mar-21-25 04:05PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-10-25 04:53PM	Mixue Group's Splashy Debut, Kroger's Change, Stuffed Crust Pizza, and Med Spas (Motley Fool) -6.63%
Mar-05-25 07:13AM	Q4 2024 Evolus Inc Earnings Call (Thomson Reuters StreetEvents)
02:09AM	Evolus Inc (EOLS) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... (GuruFocus.com)
Mar-04-25 05:25PM	Evolus, Inc. (EOLS) Q4 Earnings and Revenues Lag Estimates (Zacks)
04:05PM	Evolus Reports Record Fourth Quarter and Full-Year 2024 Financial Results; Reaffirms 2025 Guidance (Business Wire)
Mar-02-25 06:08PM	Is Evolus, Inc. (EOLS) the Best Small Cap Pharma Stock to Buy Now? (Insider Monkey)
Feb-27-25 08:00AM	Evolus to Participate in Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences (Business Wire)
Feb-20-25 08:00AM	Evolus to Participate in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit (Business Wire)
08:00AM	Loading…
Feb-18-25 08:00AM	Evolus to Report Fourth Quarter and Year End 2024 Results on March 4, 2025 (Business Wire)
Feb-14-25 08:53AM	Evolus (EOLS) Moves 5.5% Higher: Will This Strength Last? (Zacks)
Feb-13-25 01:30PM	Evolus Announces FDA Approval of Evolysse Form and Evolysse Smooth Injectable Hyaluronic Acid Gels (Business Wire) +5.47%
Feb-07-25 07:09PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jan-22-25 07:46AM	Evolus (EOLS) Surges 28.3%: Is This an Indication of Further Gains? (Zacks)
Jan-21-25 04:04PM	Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere Here's Why (Investor's Business Daily) +28.26%
08:00AM	Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Net Revenue, Achieving Record Results at the Top of the Companys Guidance (Business Wire)
Jan-17-25 04:05PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Dec-13-24 04:05PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Nov-18-24 09:55AM	Here's Why Evolus (EOLS) Could be Great Choice for a Bottom Fisher (Zacks)
Nov-14-24 09:35AM	Down -29.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Evolus (EOLS) (Zacks)
Nov-07-24 06:00AM	Evolus Inc (EOLS) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Market Challenges (GuruFocus.com) -14.99%
Nov-06-24 06:25PM	Evolus, Inc. (EOLS) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Evolus Reports Third Quarter 2024 Results (Business Wire)
Nov-01-24 08:00AM	Evolus to Participate in Stifel 2024 Healthcare Conference (Business Wire)
Oct-31-24 02:02PM	Evolus Announces EU Approval of Estyme Injectable Hyaluronic Acid Gels Under New Medical Device Regulation (Business Wire)
Oct-30-24 10:01AM	Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know (Zacks)
Oct-29-24 08:00AM	Evolus Rewards Patient Loyalty Program Surpasses 1 Million Enrolled Consumers (Business Wire)
Oct-23-24 08:00AM	Evolus to Report Third Quarter Financial Results on November 6, 2024 (Business Wire)
Oct-11-24 10:53PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Oct-09-24 03:36PM	Evolus Inc (EOLS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements (GuruFocus.com)
Sep-27-24 09:00PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-06-24 08:00AM	Evolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024 (Business Wire)
Aug-09-24 04:30PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
07:39AM	Evolus, Inc. (EOLS): Is It One of Caligan Partners Top Holdings Now? (Insider Monkey)
Aug-01-24 04:00PM	Evolus, A Medical Aesthetics Player, Becomes Profitable Two Quarters Early (Investor's Business Daily) +13.04%
Jul-31-24 09:56PM	EOLS Stock Earnings: Evolus Misses EPS, Beats Revenue for Q2 2024 (InvestorPlace)
06:45PM	Evolus, Inc. (EOLS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Evolus Reports Second Quarter 2024 Results and Raises Full Year Revenue Guidance (Business Wire)
08:00AM	Evolus to Hold Investor Day on September 12, 2024 (Business Wire)
Jul-30-24 08:00AM	Evolus Expands Global Footprint with Introduction of Nuceiva (botulinum toxin type A) in Australia (Business Wire)
Jul-25-24 08:00AM	Evolus to Participate in the Canaccord Genuity 44th Annual Growth Conference (Business Wire)
Jul-23-24 07:03AM	Evoluss frown line treatment Jeuveau could threaten Botox revenues (Pharmaceutical Technology)
Jul-17-24 08:00AM	Evolus to Report Second Quarter Financial Results on July 31, 2024 (Business Wire)
Jul-01-24 08:00AM	Evolus Announces Appointment of Albert G. White III to Board of Directors (Business Wire)
Jun-24-24 08:00AM	Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for First Two Evolysse Dermal Filler Products (Business Wire)
Jun-12-24 08:00AM	Evolus Broadens International Presence with Launch of Nuceiva (botulinum toxin type A) in Spain (Business Wire)
Jun-07-24 05:00PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -5.73%
May-28-24 01:00AM	The Evolution of Medical Aesthetics and Its Growing Foothold in the Beauty Space (WWD)
May-21-24 10:57AM	Evolus (EOLS) Releases Favorable Dermal Fillers Study Data (Zacks)
May-20-24 08:30AM	Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse Dermal Filler Products at 2024 SCALE Meeting (Business Wire)
May-16-24 02:54AM	Director David Gill Sells 10,361 Shares of Evolus Inc (EOLS) (GuruFocus.com)
02:54AM	Director Vikram Malik Sells 28,000 Shares of Evolus Inc (EOLS) (GuruFocus.com)
May-15-24 08:30AM	Evolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau at the Women's Wear Daily Beauty CEO Summit (Business Wire)
May-10-24 06:55PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
09:10AM	Evolus Sandra Beaver Named Orange County Business Journals Public Company CFO of the Year (Business Wire)
May-08-24 11:09AM	Evolus, Inc. (NASDAQ:EOLS) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:24AM	Q1 2024 Evolus Inc Earnings Call (Thomson Reuters StreetEvents)
03:53AM	Evolus Inc (EOLS) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth and Strategic ... (GuruFocus.com)
May-07-24 08:58PM	EOLS Stock Earnings: Evolus Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:35PM	Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:46PM	Evolus Inc (EOLS) Q1 2024 Earnings: Surpasses Revenue Estimates with Significant Growth (GuruFocus.com)
04:05PM	Evolus Reports First Quarter 2024 Results and Provides Business Update (Business Wire)
May-02-24 07:37AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
Apr-23-24 04:30PM	Evolus to Report First Quarter Financial Results on May 7, 2024 (Business Wire)
Apr-21-24 10:39AM	11 Best Low Price Pharma Stocks To Invest In (Insider Monkey)
Apr-17-24 04:05PM	Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for Extra-Strength 40U Formulation of Jeuveau (Business Wire)
Apr-12-24 04:05PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-26-24 08:00AM	Evolus to Participate in the 23rd Annual Needham Virtual Healthcare Conference (Business Wire)
Mar-14-24 07:04AM	10 Stocks George Soros and Insiders Are Crazy About (Insider Monkey)
Mar-13-24 09:55AM	Does Evolus, Inc. (EOLS) Have the Potential to Rally 63.24% as Wall Street Analysts Expect? (Zacks)
Mar-11-24 07:00AM	Evolus Announces Pricing of $50.0 Million Underwritten Offering of Common Stock (Business Wire)
Mar-08-24 04:05PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
03:24PM	Evolus, Inc. (NASDAQ:EOLS) Q4 2023 Earnings Call Transcript (Insider Monkey)
12:30PM	Q4 2023 Evolus Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-07-24 10:34PM	Evolus Inc (EOLS) Reports Record Revenues in Q4 and Full Year 2023, Eyes Profitability in 2024 (GuruFocus.com)
09:53PM	EOLS Stock Earnings: Evolus Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
04:05PM	Evolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 Guidance (Business Wire)
Mar-04-24 08:28PM	11 Best Small Cap Pharma Stocks to Invest In (Insider Monkey)
Mar-01-24 08:30AM	Evolus Announces Results from European Head-to-Head Filler Trial (Business Wire)

Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MOATAZEDI DAVID	See Remarks	Jun 13 '25	Sale	10.05	111,323	1,119,141	381,509	Jun 16 04:42 PM
MOATAZEDI DAVID	See Remarks	Jun 16 '25	Sale	9.89	16,582	164,054	364,927	Jun 16 04:42 PM
DAVID MOATAZEDI	Officer	Jun 16 '25	Proposed Sale	9.89	16,582	164,052		Jun 16 04:03 PM
DAVID MOATAZEDI	Officer	Jun 13 '25	Proposed Sale	10.05	111,323	1,119,141		Jun 13 05:23 PM
White Albert G III	Director	Jun 09 '25	Buy	9.45	20,000	189,000	50,378	Jun 10 05:04 PM
Avelar Rui	See Remarks	May 12 '25	Sale	9.87	3,385	33,397	359,082	May 14 07:27 PM
Beaver Sandra	Chief Financial Officer	May 13 '25	Sale	10.02	6,494	65,070	167,089	May 14 07:27 PM
MOATAZEDI DAVID	See Remarks	May 12 '25	Sale	9.87	15,787	155,756	492,832	May 14 07:27 PM
MOATAZEDI DAVID	See Remarks	Mar 27 '25	Sale	12.40	6,251	77,512	508,619	Mar 28 06:59 PM
Avelar Rui	See Remarks	Mar 18 '25	Sale	13.26	27,904	369,868	362,467	Mar 20 06:27 PM
Beaver Sandra	Chief Financial Officer	Mar 18 '25	Sale	13.26	8,996	119,243	173,583	Mar 20 06:27 PM
Yamagishi-Dressler Tomoko	Chief Marketing Officer	Mar 18 '25	Sale	13.26	4,536	60,125	95,671	Mar 20 06:27 PM
MOATAZEDI DAVID	See Remarks	Mar 18 '25	Sale	13.26	103,376	1,370,249	514,870	Mar 20 06:27 PM
Parschauer Karah Herdman	Director	Mar 12 '25	Sale	12.99	12,888	167,465	32,183	Mar 14 05:59 PM
Parschauer Karah Herdman	Director	Mar 12 '25	Proposed Sale	12.99	12,888	167,465		Mar 12 05:55 PM
Avelar Rui	See Remarks	Dec 23 '24	Sale	10.85	2,252	24,438	366,595	Dec 26 05:28 PM
Beaver Sandra	Chief Financial Officer	Dec 23 '24	Sale	10.85	1,586	17,211	146,916	Dec 26 05:28 PM
MOATAZEDI DAVID	See Remarks	Dec 23 '24	Sale	10.85	10,502	113,967	522,847	Dec 26 05:28 PM
Beaver Sandra	Chief Financial Officer	Sep 06 '24	Sale	14.98	3,276	49,074	148,502	Sep 06 09:45 PM
Yamagishi-Dressler Tomoko	Chief Marketing Officer	Aug 30 '24	Sale	15.85	5,631	89,251	82,375	Sep 04 04:14 PM

Dollar change -0.98
Percentage change -1.41	%

COO Cooper Companies, Inc daily Stock Chart

Peers: ALGN SYK JNJ ISRG BSX ZBH MDT BAX HOLX STE

| Held by: VTI VOO VO SPY IVV VTV RSP VOT XLV IWR

Index	S&P 500	P/E	33.35	EPS (ttm)	2.06	Insider Own	0.65%	Shs Outstand	199.50M	Perf Week	-5.41%
Market Cap	13.72B	Forward P/E	15.57	EPS next Y	4.42	Insider Trans	0.00%	Shs Float	198.21M	Perf Month	-17.08%
Income	414.20M	PEG	3.52	EPS next Q	1.07	Inst Own	100.92%	Short Float	2.54%	Perf Quarter	-14.09%
Sales	3.99B	P/S	3.44	EPS this Y	10.28%	Inst Trans	2.21%	Short Ratio	2.19	Perf Half Y	-28.91%
Book/sh	41.54	P/B	1.66	EPS next Y	8.50%	ROA	3.39%	Short Interest	5.04M	Perf Year	-27.01%
Cash/sh	0.58	P/C	118.06	EPS next 5Y	9.48%	ROE	5.15%	52W Range	65.00 - 112.38	Perf YTD	-25.20%
Dividend Est.	0.02 (0.03%)	P/FCF	37.49	EPS past 5Y	-3.45%	ROIC	3.83%	52W High	-38.81%	Beta	0.99
Dividend TTM	-	Quick Ratio	1.23	Sales past 5Y	7.98%	Gross Margin	62.18%	52W Low	5.78%	ATR (14)	2.35
Dividend Ex-Date	Jul 26, 2023	Current Ratio	2.10	EPS Y/Y TTM	21.11%	Oper. Margin	19.00%	RSI (14)	34.20	Volatility	0.77% 3.93%
Employees	16000	Debt/Eq	0.31	Sales Y/Y TTM	6.88%	Profit Margin	10.39%	Recom	1.90	Target Price	92.71
Option/Short	Yes / Yes	LT Debt/Eq	0.30	EPS Q/Q	-1.44%	Payout	0.00%	Rel Volume	1.39	Prev Close	69.74
Sales Surprise	0.70%	EPS Surprise	3.47%	Sales Q/Q	6.33%	Earnings	May 29 AMC	Avg Volume	2.30M	Price	68.76
SMA20	-6.32%	SMA50	-11.19%	SMA200	-25.56%	Trades		Volume	3,223,254	Change	-1.41%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-17-25	Upgrade	Needham	Hold → Buy	$94
May-30-25	Downgrade	JP Morgan	Overweight → Neutral	$76
Aug-29-24	Reiterated	Piper Sandler	Overweight	$115 → $120
Jul-16-24	Upgrade	Jefferies	Hold → Buy	$107 → $115
Mar-19-24	Upgrade	Redburn Atlantic	Neutral → Buy	$125
Mar-13-24	Upgrade	JP Morgan	Neutral → Overweight	$100 → $120
Feb-06-24	Resumed	KeyBanc Capital Markets	Sector Weight
Oct-30-23	Initiated	BofA Securities	Buy	$380
Oct-05-23	Downgrade	Redburn Atlantic	Overweight → Neutral	$390 → $343
May-30-23	Initiated	Morgan Stanley	Equal-Weight	$410
Dec-22-22	Initiated	Mizuho	Buy	$375
Nov-30-22	Upgrade	Robert W. Baird	Neutral → Outperform	$345 → $375
Oct-12-22	Downgrade	Jefferies	Buy → Hold	$400 → $295
Aug-29-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-17-22	Upgrade	Citigroup	Neutral → Buy	$460 → $405
Apr-08-22	Initiated	Needham	Hold
Jan-03-22	Upgrade	Guggenheim	Neutral → Buy
Sep-03-21	Reiterated	Stifel	Buy	$450 → $475
Sep-03-21	Reiterated	Oppenheimer	Perform	$405 → $475
Sep-03-21	Reiterated	KeyBanc Capital Markets	Overweight	$444 → $476

Show Previous Ratings

Jun-07-25 09:47AM	3 Oversold Stocks Flashing Bullish Reversal Signals (MarketBeat)
Jun-05-25 05:37PM	S&P 500 Gains and Losses Today: Tesla Shares Skid as Trump and Musk Tussle Over Budget Bill (Investopedia) +5.58%
Jun-03-25 09:45AM	Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term (Zacks)
Jun-02-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
09:15AM	Understanding The Cooper Companies (COO) Reliance on International Revenue (Zacks)
08:43AM	Loading…
08:43AM	COO Q2 Earnings Signal Growth and Caution: How to Play the Stock? (Zacks)
May-30-25 08:47PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research) -14.61%
02:13PM	Cooper Stock Sinks as Contact Lens Maker Cuts Full-Year Organic Growth Forecast (Investopedia)
12:41PM	Why CooperCompanies (COO) Stock Is Falling Today (StockStory)
11:59AM	Top Stock Movers Now: Regeneron, Ulta Beauty, Cooper, and More (Investopedia)
11:40AM	XRAY vs. COO: Which Stock Should Value Investors Buy Now? (Zacks)
09:32AM	COO Q2 Earnings Beat, 2025 Sales Outlook Tightened, Stock Down (Zacks)
03:08AM	The Cooper Companies Inc (COO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
May-29-25 09:10PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
06:00PM	The Cooper Companies (COO) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:30PM	Loading…
05:30PM	The Cooper Companies (COO) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
04:51PM	CooperCompanies's (NASDAQ:COO) Q1 Sales Beat Estimates (StockStory)
04:30PM	The Cooper Companies: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	CooperCompanies Announces Second Quarter 2025 Results (GlobeNewswire)
09:29AM	Reasons to Retain The Cooper Companies Stock in Your Portfolio Now (Zacks)
May-28-25 03:03AM	CooperCompanies (COO) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
May-23-25 09:15AM	Insights Into The Cooper Companies (COO) Q2: Wall Street Projections for Key Metrics (Zacks)
May-22-25 09:18AM	Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick (Investing.com)
May-20-25 04:15PM	CooperCompanies' 2024 Sustainability Report Showcases Efforts that Benefit People and the Planet (GlobeNewswire)
07:48AM	Cooper Companies Q2 Earnings Likely to Reflect Seasonal Trends (Zacks)
May-15-25 06:35PM	Zomedica Corp. (ZOMDF) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-14-25 11:40AM	XRAY or COO: Which Is the Better Value Stock Right Now? (Zacks)
07:47AM	The Cooper Companies, Inc. (COO): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying (Insider Monkey)
May-12-25 07:33PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
May-08-25 04:15PM	CooperCompanies to Participate in the William Blair Growth Stock Conference (GlobeNewswire)
07:10AM	Loading…
07:10AM	Dentsply International (XRAY) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
12:36AM	3 Cash-Producing Stocks Facing Headwinds (StockStory)
May-07-25 05:45PM	Staar Surgical (STAA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-06-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
May-01-25 07:55AM	Cardinal Health (CAH) Beats Q3 Earnings Estimates (Zacks)
Apr-30-25 04:15PM	CooperCompanies Appoints Barbara Carbone to Board of Directors (GlobeNewswire)
Apr-29-25 04:15PM	CooperCompanies Announces Release Date for Second Quarter 2025 (GlobeNewswire)
Apr-21-25 10:40AM	The Wyatt Foundation and The Conceive Fertility Foundation Announce Launch of 2025 IVF Grant Program (PR Newswire)
Apr-17-25 11:17AM	Despite Some Deterioration, Utah Medical Products Is A Solid Play (Seeking Alpha)
Apr-03-25 07:36PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research) -5.63%
05:04AM	CooperCompanies (COO): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
Mar-24-25 07:30PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
Mar-17-25 03:12PM	The Cooper Companies, Inc. (NASDAQ:COO): An Eye-Catching Proposal (Insider Monkey)
Mar-13-25 07:24PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
05:04AM	Q4 Earnings Roundup: CooperCompanies (NASDAQ:COO) And The Rest Of The Medical Devices & Supplies - Diversified Segment (StockStory)
Mar-08-25 03:39PM	Why The Cooper Companies, Inc. (COO) Went Down on Friday (Insider Monkey)
Mar-07-25 04:35PM	S&P 500 Gains and Losses Today: Broadcom Stock Surges as Chipmaker Touts AI Revenue Growth (Investopedia) -6.57% -6.01%
12:13PM	Why CooperCompanies (COO) Stock Is Trading Lower Today (StockStory)
02:17AM	The Cooper Companies Inc (COO) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
Mar-06-25 07:21PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
06:00PM	The Cooper Companies (COO) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:25PM	The Cooper Companies (COO) Matches Q1 Earnings Estimates (Zacks)
04:26PM	The Cooper Companies: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:25PM	CooperCompanies (NASDAQ:COO) Misses Q4 Revenue Estimates, Stock Drops 11% (StockStory)
04:15PM	CooperCompanies Announces First Quarter 2025 Results (GlobeNewswire)
Mar-05-25 08:03AM	What To Expect From CooperCompaniess (COO) Q4 Earnings (StockStory)
Mar-03-25 09:15AM	What Analyst Projections for Key Metrics Reveal About The Cooper Companies (COO) Q1 Earnings (Zacks)
Feb-21-25 08:01AM	1 Healthcare Stock to Hold Forever and 2 to Ignore (StockStory)
Feb-03-25 04:15PM	CooperCompanies Announces Release Date for First Quarter 2025 (GlobeNewswire)
Jan-08-25 08:46AM	Are Options Traders Betting on a Big Move in Cooper Companies (COO) Stock? (Zacks)
Dec-17-24 04:15PM	CooperCompanies to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-13-24 07:36PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
Dec-09-24 09:15AM	The Cooper Companies (COO) International Revenue in Focus: Trends and Expectations (Zacks)
Dec-06-24 09:47AM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
08:16AM	Q4 2024 CooperCompanies Inc Earnings Call (Thomson Reuters StreetEvents)
02:03AM	The Cooper Companies Inc (COO) Q4 2024 Earnings Call Highlights: Record Revenues and Strategic ... (GuruFocus.com)
Dec-05-24 07:00PM	The Cooper Companies (COO) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:25PM	The Cooper Companies (COO) Q4 Earnings Beat Estimates (Zacks)
04:34PM	The Cooper Companies: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:15PM	CooperCompanies Announces Fourth Quarter and Full Year 2024 Results (GlobeNewswire)
Dec-02-24 01:29PM	Unveiling The Cooper Companies (COO) Q4 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Nov-28-24 12:22PM	Meridian Growth Fund Trimmed The Cooper Companies (COO) For Valuation Discipline (Insider Monkey)
Nov-12-24 04:15PM	CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2024 (GlobeNewswire)
Oct-30-24 08:10AM	What Makes The Cooper Companies (COO) a Strong Investment? (Insider Monkey)
Sep-19-24 12:00PM	The Cooper Companies (COO) is a Great Momentum Stock: Should You Buy? (Zacks)
Sep-12-24 09:55AM	After Golden Cross, The Cooper Companies (COO)'s Technical Outlook is Bright (Zacks)
Sep-10-24 04:28PM	CooperCompanies Recognized as a Best Workplace for Innovators (GlobeNewswire)
Sep-03-24 04:15PM	CooperSurgical Launches Paragard Intrauterine Copper Contraceptive with New Single-Hand Inserter (Business Wire)
Sep-02-24 09:15AM	A Dive into The Cooper Companies (COO) International Revenue Trends and Forecasts (Zacks)
Aug-30-24 01:24AM	Decoding The Cooper Companies Inc (COO): A Strategic SWOT Insight (GuruFocus.com)
Aug-29-24 06:35PM	Why Cooper Companies Stock Triumphed on Thursday (Motley Fool) +11.84%
11:06AM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
10:52AM	Q3 2024 Cooper Companies Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-28-24 06:00PM	Compared to Estimates, The Cooper Companies (COO) Q3 Earnings: A Look at Key Metrics (Zacks)
05:25PM	The Cooper Companies (COO) Q3 Earnings and Revenues Surpass Estimates (Zacks)
04:26PM	The Cooper Companies: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	CooperCompanies Announces Third Quarter 2024 Results (GlobeNewswire)
Aug-27-24 09:02AM	What To Expect From The Cooper Companies Inc (COO) Q3 2024 Earnings (GuruFocus.com)
Aug-26-24 12:10PM	Will The Cooper Companies (COO) Beat Estimates Again in Its Next Earnings Report? (Zacks)
08:28AM	What's in Store for Cooper Companies (COO) in Q3 Earnings? (Zacks)
Aug-23-24 12:00PM	Reasons to Add The Cooper Companies (COO) to Your Portfolio Now (Zacks)
09:15AM	Unveiling The Cooper Companies (COO) Q3 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Aug-08-24 04:15PM	CooperCompanies to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-06-24 04:15PM	CooperCompanies Announces Release Date for Third Quarter 2024 (GlobeNewswire)
Aug-01-24 04:15PM	CooperCompanies Acquires obp Surgical, Expanding CooperSurgical's Portfolio of Leading Medical Devices (GlobeNewswire)
Jul-24-24 08:04AM	Reasons to Add The Cooper Companies (COO) to Your Portfolio Now (Zacks)
Jul-15-24 02:00AM	CooperVision Champions Children's Eye Health at WCPOS V 2024 (PR Newswire)
Jun-18-24 07:54AM	Reasons to Retain The Cooper Companies (COO) in Your Portfolio Now (Zacks)
Jun-01-24 01:04AM	Decoding The Cooper Companies Inc (COO): A Strategic SWOT Insight (GuruFocus.com)
May-31-24 11:41AM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)

The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KOZY WILLIAM A	Director	Apr 01 '25	Option Exercise	0.00	2,857	0	31,149	Apr 03 04:09 PM
WEISS ROBERT S	Director	Apr 01 '25	Option Exercise	0.00	2,993	0	288,945	Apr 03 04:09 PM
Rivas Maria	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	2,721	Apr 03 04:08 PM
MADDEN TERESA S	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	12,357	Apr 03 04:08 PM
Lucchese Cynthia L	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	7,661	Apr 03 04:07 PM
Kurzius Lawrence Erik	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	3,777	Apr 03 04:07 PM
Jay Colleen	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	29,521	Apr 03 04:06 PM
Ricupati Agostino	SVP & CAO	Apr 01 '25	Option Exercise	0.00	2,076	0	9,044	Apr 03 04:06 PM
McBride Daniel G	EVP & Chief Operating Officer	Feb 01 '25	Option Exercise	0.00	22,777	0	71,687	Feb 04 04:25 PM
White Albert G III	President & CEO	Feb 01 '25	Option Exercise	0.00	84,264	0	258,941	Feb 04 04:25 PM
Andrews Brian G	EVP, CFO & Treasurer	Feb 01 '25	Option Exercise	0.00	16,850	0	23,464	Feb 04 04:24 PM
Sheffield Holly R	President, CSI	Feb 01 '25	Option Exercise	0.00	17,309	0	45,843	Feb 04 04:24 PM
White Albert G III	President & CEO	Jan 08 '25	Option Exercise	0.00	18,340	0	183,613	Jan 10 04:12 PM
Warner Gerard H III	President, CooperVision, Inc.	Jan 08 '25	Option Exercise	0.00	13,328	0	23,763	Jan 10 04:12 PM
Sheffield Holly R	President, CSI	Jan 08 '25	Option Exercise	0.00	4,900	0	30,898	Jan 10 04:11 PM
Ricupati Agostino	SVP & CAO	Jan 08 '25	Option Exercise	0.00	4,472	0	9,328	Jan 10 04:11 PM
McBride Daniel G	EVP & Chief Operating Officer	Jan 08 '25	Option Exercise	0.00	8,728	0	53,424	Jan 10 04:11 PM
Andrews Brian G	EVP, CFO & Treasurer	Jan 08 '25	Option Exercise	0.00	6,420	0	13,034	Jan 10 04:10 PM
Khadder Nicholas	VP, General Counsel & Corp Sec	Jan 08 '25	Option Exercise	0.00	3,492	0	4,369	Jan 10 04:10 PM
White Albert G III	President & CEO	Sep 19 '24	Option Exercise	43.83	114,992	5,040,099	280,265	Sep 20 05:51 PM
White Albert G III	President & CEO	Sep 19 '24	Sale	110.53	114,992	12,710,041	165,273	Sep 20 05:51 PM
Albert G. White III	Officer	Sep 19 '24	Proposed Sale	110.53	114,992	12,709,660		Sep 19 03:53 PM
Ricupati Agostino	SVP & CAO	Sep 10 '24	Sale	108.03	1,601	172,955	4,818	Sep 11 05:50 PM
Agostino Ricupati	Director	Sep 10 '24	Proposed Sale	108.03	1,601	172,950		Sep 10 01:47 PM
Andrews Brian G	EVP, CFO & Treasurer	Sep 05 '24	Option Exercise	37.91	24,788	939,734	31,402	Sep 06 04:58 PM
Andrews Brian G	EVP, CFO & Treasurer	Sep 05 '24	Sale	105.90	24,788	2,625,072	6,614	Sep 06 04:58 PM
McBride Daniel G	EVP & Chief Operating Officer	Sep 04 '24	Option Exercise	43.83	114,992	5,040,099	159,688	Sep 06 04:56 PM
McBride Daniel G	EVP & Chief Operating Officer	Sep 04 '24	Sale	105.48	114,992	12,129,911	44,696	Sep 06 04:56 PM
Brian G. Andrews	Officer	Sep 05 '24	Proposed Sale	105.90	24,788	2,624,952		Sep 05 01:22 PM
Daniel McBride	Officer	Sep 04 '24	Proposed Sale	105.48	114,992	12,129,545		Sep 04 04:18 PM

EOLS

Evolus Inc

COO

Cooper Companies, Inc

Upgrade your FINVIZ experience